Clinical trial
Interleukin-2 in Treating Patients With Mycosis Fungoides
NCT00002687 · University of Washington, Other · Completed
Key facts
| NCT number | NCT00002687 |
|---|---|
| Title | Interleukin-2 in Treating Patients With Mycosis Fungoides |
| Official title | Phase 1 Trial of Subcutaneous [SC]; Outpatient Interleukin-2 for Patients With Advanced Mycosis Fungoides [Stage IIb, III, IV] |
| Lead sponsor | University of Washington, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological |
| Interventions | aldesleukin |
| Enrollment | 30 |
| Start date | Feb 1, 1995 |
| Primary completion | Jul 1, 2003 |
| Completion | Jul 1, 2003 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 4, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: